Having trouble accessing articles? Reset your cache.

Lexiscan regadenoson: Phase IV data

A double-blind Phase IV trial in 999 patients with asthma (n=532) or chronic obstructive pulmonary disease (COPD) (n=467) who

Read the full 195 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE